Patents by Inventor Sang-Mi Jin

Sang-Mi Jin has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 8178688
    Abstract: The present invention relates to novel benzamidine derivatives, process for the preparation thereof and pharmaceutical composition comprising the same. The novel benzamidine derivatives of the present invention are useful for the prevention and treatment of osteoporosis, bone fractures and allergic inflammatory diseases.
    Type: Grant
    Filed: August 4, 2005
    Date of Patent: May 15, 2012
    Assignee: Dong Wha Pharmaceutical Co., Ltd.
    Inventors: Jin Soo Lee, Seok Hoon Ahn, Young Goo Jin, Sang Mi Jin, Whui-Jung Park, Sae Kwang Ku, Yun Ha Hwang, Pan Soo Kim, Sun Shin Yi, Jei Man Ryu
  • Publication number: 20100240890
    Abstract: The present invention relates to novel benzamidine derivatives, process for the preparation thereof and pharmaceutical composition comprising the same. The novel benzamidine derivatives of the present invention are useful for the prevention and treatment of osteoporosis, bone fractures and allergic inflammatory diseases.
    Type: Application
    Filed: August 4, 2005
    Publication date: September 23, 2010
    Inventors: Jin Soo Lee, Seok Hoon Ahn, Young Goo Jin, Sang Mi Jin, Whui-Jung Park, Sae Kwang Ku, Yu Ha Hwang, Pan Soo Kim, Sun Shin Yi, Jei Man Ryu
  • Patent number: 7291638
    Abstract: The present invention relates to 3-amido-1,2-benzoisoxazole derivatives and their salts represented by formula 1, processes for preparation and usees thereof. More particularly, it relates to a method for improving its bioavailability introducing amino acid residue to the amine group of a 3-amido-1,2-benzoisoxazole. The compounds according to the present invention are used as an antagonist against Leukotriene-B-4 receptor, an inhibitor or therapeutics of osteoroposis, thus inhibiting osteolysis and stimulating osteogensis.
    Type: Grant
    Filed: November 5, 2002
    Date of Patent: November 6, 2007
    Assignee: Dongwha Pharm. Ind. Co., Ltd.
    Inventors: Jin-Soo Lee, Seok-Hoon Ahn, Young-Goo Jin, Sang-Mi Jin, Sae-Kwang Ku, Jei-Man Rye, Yong-Ho Chung, Eun-Joo Kim, Sun-Ki Cho
  • Publication number: 20050020650
    Abstract: The present invention relates to 3-amido-1,2-benzoisoxazole derivatives and their salts represented by formula 1, processes for preparation and usees thereof. More particularly, it relates to a method for improving its bioavailability introducing amino acid residue to the amine group of a 3-amido-1,2-benzoisoxazole. The compounds according to the present invention are used as an antagonist against Leukotriene-B-4 receptor, an inhibitor or therapeutics of osteoroposis, thus inhibiting osteolysis and stimulating osteogensis.
    Type: Application
    Filed: November 5, 2002
    Publication date: January 27, 2005
    Inventors: Jin-Soo Lee, Seok-Hoon Ahn, Young-Goo Jin, Sang-Mi Jin, Sae-Kwang Ku, Jei-Man Rye, Yong-Ho Chung, Eun-Joo Kim, Sun-Ki Cho